Pfizer and BioNTech plan to initiate U.S. COVID-19 Vaccine Trial

The companies are collaborating on a messenger RNA vaccine against SARS-CoV-2 and have already begun Phase I/II clinical testing in Germany, with 12 patients out of a target population of 200 already dosed. They now plan to start testing in the US once FDA approval granted.


Biospace Inc.